These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12769789)

  • 1. Targeted inhibition of angiogenic factors in AIDS-related disorders.
    Aoki Y; Tosato G
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):115-28. PubMed ID: 12769789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
    J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
    Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
    Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?
    Fiorelli V; Gendelman R; Sirianni MC; Chang HK; Colombini S; Markham PD; Monini P; Sonnabend J; Pintus A; Gallo RC; Ensoli B
    Blood; 1998 Feb; 91(3):956-67. PubMed ID: 9446657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Staskus KA; Sun R; Miller G; Racz P; Jaslowski A; Metroka C; Brett-Smith H; Haase AT
    J Virol; 1999 May; 73(5):4181-7. PubMed ID: 10196314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J; Maruyama I
    Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KSHV-Mediated Angiogenesis in Tumor Progression.
    Purushothaman P; Uppal T; Sarkar R; Verma SC
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27447661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
    J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
    Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
    J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
    Li S; Bai L; Dong J; Sun R; Lan K
    Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
    Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
    Dezube BJ; Sullivan R; Koon HB
    J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
    Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
    Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy.
    Cannon M; Cesarman E
    Semin Oncol; 2000 Aug; 27(4):409-19. PubMed ID: 10950367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
    Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and manifestations of human herpesvirus-8-associated disorders.
    Aoki Y; Tosato G
    Semin Hematol; 2003 Apr; 40(2):143-53. PubMed ID: 12704591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
    Sakakibara S; Tosato G
    J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
    Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
    J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma and other manifestations of human herpesvirus 8.
    Geraminejad P; Memar O; Aronson I; Rady PL; Hengge U; Tyring SK
    J Am Acad Dermatol; 2002 Nov; 47(5):641-55; quiz 656-8. PubMed ID: 12399755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.